-
1
-
-
0041629528
-
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
-
Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2636-2644
-
-
Vogelzang, N.J.1
Rusthoven, J.J.2
Symanowski, J.3
-
2
-
-
70349748532
-
Current status of screening for malignant pleural mesothelioma
-
Pass HI, Carbone M. Current status of screening for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 2009;21:97-104.
-
(2009)
Semin Thorac Cardiovasc Surg
, vol.21
, pp. 97-104
-
-
Pass, H.I.1
Carbone, M.2
-
3
-
-
84862991636
-
Serum mesothelin for diagnosing malignant pleural mesothelioma: An individual patient data meta-analysis
-
Hollevoet K, Reitsma JB, Creaney J, et al. Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol 2012;30:1541-9.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1541-1549
-
-
Hollevoet, K.1
Reitsma, J.B.2
Creaney, J.3
-
4
-
-
26444506232
-
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels
-
Pass HI, Lott D, Lonardo F, et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 2005;353:1564-73.
-
(2005)
N Engl J Med
, vol.353
, pp. 1564-1573
-
-
Pass, H.I.1
Lott, D.2
Lonardo, F.3
-
5
-
-
10744226290
-
Gene expression profiles predict survival and progression of pleural mesothelioma
-
Pass HI, Liu Z, Wali A, et al. Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res 2004;10:849-59.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 849-859
-
-
Pass, H.I.1
Liu, Z.2
Wali, A.3
-
6
-
-
0028825114
-
A proposed new international TNM staging system for malignant pleural mesothelioma
-
Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 1995;108:1122-8.
-
(1995)
Chest
, vol.108
, pp. 1122-1128
-
-
Rusch, V.W.1
-
7
-
-
0026701743
-
Use of death certificates in epidemiological studies, including occupational hazards: Variations in discordance of different asbestos-associated diseases on best evidence ascertainment
-
Selikoff IJ, Seidman H. Use of death certificates in epidemiological studies, including occupational hazards: variations in discordance of different asbestos-associated diseases on best evidence ascertainment. Am J Ind Med 1992;22:481-92.
-
(1992)
Am J Ind Med
, vol.22
, pp. 481-492
-
-
Selikoff, I.J.1
Seidman, H.2
-
8
-
-
9844232632
-
The CARET asbestos-exposed cohort: Baseline characteristics and comparison to other asbestos-exposed cohorts
-
Barnhart S, Keogh J, Cullen MR, et al. The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohorts. Am J Ind Med 1997;32:573-81.
-
(1997)
Am J Ind Med
, vol.32
, pp. 573-581
-
-
Barnhart, S.1
Keogh, J.2
Cullen, M.R.3
-
9
-
-
67651176229
-
Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure
-
Roberts HC, Patsios DA, Paul NS, et al. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J Thorac Oncol 2009;4:620-8.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 620-628
-
-
Roberts, H.C.1
Patsios, D.A.2
Paul, N.S.3
-
10
-
-
0018079655
-
Basic principles of ROC analysis
-
Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-98.
-
(1978)
Semin Nucl Med
, vol.8
, pp. 283-298
-
-
Metz, C.E.1
-
11
-
-
0027457620
-
Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine
-
Erratum, Clin Chem 1993;39:1589
-
Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77. [Erratum, Clin Chem 1993;39:1589.]
-
(1993)
Clin Chem
, vol.39
, pp. 561-577
-
-
Zweig, M.H.1
Campbell, G.2
-
12
-
-
0020083498
-
The meaning and use of the area under a receiver operating characteristic (ROC) curve
-
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
-
(1982)
Radiology
, vol.143
, pp. 29-36
-
-
Hanley, J.A.1
McNeil, B.J.2
-
13
-
-
0030958107
-
Human fibulin-1D: Molecular cloning, expression and similarity with S1-5 protein, a new member of the fibulin gene family
-
Tran H, Mattei M, Godyna S, Argraves WS. Human fibulin-1D: molecular cloning, expression and similarity with S1-5 protein, a new member of the fibulin gene family. Matrix Biol 1997;15:479-93.
-
(1997)
Matrix Biol
, vol.15
, pp. 479-493
-
-
Tran, H.1
Mattei, M.2
Godyna, S.3
Argraves, W.S.4
-
14
-
-
0029808227
-
Different susceptibilities of fibulin-1 and fibulin-2 to cleavage by matrix metalloproteinases and other tissue proteases
-
Sasaki T, Mann K, Murphy G, Chu ML, Timpl R. Different susceptibilities of fibulin-1 and fibulin-2 to cleavage by matrix metalloproteinases and other tissue proteases. Eur J Biochem 1996;240:427-34.
-
(1996)
Eur J Biochem
, vol.240
, pp. 427-434
-
-
Sasaki, T.1
Mann, K.2
Murphy, G.3
Chu, M.L.4
Timpl, R.5
-
15
-
-
77649187192
-
Focus on molecules: Fibulin-3 (EFEMP1)
-
Zhang Y, Marmorstein LY. Focus on molecules: fibulin-3 (EFEMP1). Exp Eye Res 2010;90:374-5.
-
(2010)
Exp Eye Res
, vol.90
, pp. 374-375
-
-
Zhang, Y.1
Marmorstein, L.Y.2
-
16
-
-
34249661138
-
A comparative analysis of the fibulin protein family: Biochemical characterization, binding interactions, and tissue localization
-
Kobayashi N, Kostka G, Garbe JH, et al. A comparative analysis of the fibulin protein family: biochemical characterization, binding interactions, and tissue localization. J Biol Chem 2007;282:11805-16.
-
(2007)
J Biol Chem
, vol.282
, pp. 11805-11816
-
-
Kobayashi, N.1
Kostka, G.2
Garbe, J.H.3
-
17
-
-
62249202023
-
Differential expression of fibulin family proteins in the para-cervical weak zone and other areas of human fetal membranes
-
Moore RM, Redline RW, Kumar D, et al. Differential expression of fibulin family proteins in the para-cervical weak zone and other areas of human fetal membranes. Placenta 2009;30:335-41.
-
(2009)
Placenta
, vol.30
, pp. 335-341
-
-
Moore, R.M.1
Redline, R.W.2
Kumar, D.3
-
18
-
-
77955282701
-
Molecular evolution of the fibulins: Implications on the functionality of the elastic fibulins
-
Segade F. Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins. Gene 2010;464:17-31.
-
(2010)
Gene
, vol.464
, pp. 17-31
-
-
Segade, F.1
-
19
-
-
33645047392
-
Fibulins 3 and 5 antagonize tumor angiogenesis in vivo
-
Albig AR, Neil JR, Schiemann WP. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 2006;66:2621-9.
-
(2006)
Cancer Res
, vol.66
, pp. 2621-2629
-
-
Albig, A.R.1
Neil, J.R.2
Schiemann, W.P.3
-
20
-
-
84862920643
-
Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation
-
Kim EJ, Lee SY, Woo MK, et al. Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation. Int J Oncol 2012;40:402-8.
-
(2012)
Int J Oncol
, vol.40
, pp. 402-408
-
-
Kim, E.J.1
Lee, S.Y.2
Woo, M.K.3
-
21
-
-
34547673238
-
Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation
-
Yue W, Dacic S, Sun Q, et al. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin Cancer Res 2007;13:4336-44.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 4336-4344
-
-
Yue, W.1
Dacic, S.2
Sun, Q.3
-
22
-
-
79960320144
-
EFEMP1 as a novel DNA methylation marker for prostate cancer: Array-based DNA methylation and expression profiling
-
Kim YJ, Yoon HY, Kim SK, et al. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling. Clin Cancer Res 2011;17:4523-30.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 4523-4530
-
-
Kim, Y.J.1
Yoon, H.Y.2
Kim, S.K.3
-
23
-
-
80052889950
-
Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis
-
Tong JD, Jiao NL, Wang YX, Zhang YW, Han F. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis. Neoplasma 2011;58:441-8.
-
(2011)
Neoplasma
, vol.58
, pp. 441-448
-
-
Tong, J.D.1
Jiao, N.L.2
Wang, Y.X.3
Zhang, Y.W.4
Han, F.5
-
24
-
-
61449089633
-
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker
-
Sadr-Nabavi A, Ramser J, Volkmann J, et al. Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer 2009;124:1727-35.
-
(2009)
Int J Cancer
, vol.124
, pp. 1727-1735
-
-
Sadr-Nabavi, A.1
Ramser, J.2
Volkmann, J.3
-
25
-
-
78349279900
-
Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity
-
Hwang CF, Chien CY, Huang SC, et al. Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity. J Pathol 2010;222:367-79.
-
(2010)
J Pathol
, vol.222
, pp. 367-379
-
-
Hwang, C.F.1
Chien, C.Y.2
Huang, S.C.3
-
26
-
-
77149138642
-
Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis
-
Nomoto S, Kanda M, Okamura Y, et al. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Ann Surg Oncol 2010;17:923-32.
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 923-932
-
-
Nomoto, S.1
Kanda, M.2
Okamura, Y.3
-
27
-
-
61349114335
-
EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma
-
Seeliger H, Camaj P, Ischenko I, et al. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma. Mol Cancer Res 2009;7:189-98.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 189-198
-
-
Seeliger, H.1
Camaj, P.2
Ischenko, I.3
-
28
-
-
72449128177
-
Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion
-
Hu B, Thirtamara-Rajamani KK, Sim H, Viapiano MS. Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion. Mol Cancer Res 2009;7:1756-70.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1756-1770
-
-
Hu, B.1
Thirtamara-Rajamani, K.K.2
Sim, H.3
Viapiano, M.S.4
-
29
-
-
80053341522
-
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment
-
Hu Y, Pioli PD, Siegel E, et al. EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment. Mol Cancer 2011;10:123.
-
(2011)
Mol Cancer
, vol.10
, pp. 123
-
-
Hu, Y.1
Pioli, P.D.2
Siegel, E.3
-
30
-
-
79953325946
-
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
-
Davidson B, Stavnes HT, Holth A, et al. Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions. J Cell Mol Med 2011;15:535-44.
-
(2011)
J Cell Mol Med
, vol.15
, pp. 535-544
-
-
Davidson, B.1
Stavnes, H.T.2
Holth, A.3
-
31
-
-
33746668234
-
Maculopathy due to the R345W substitution in fibulin-3: Distinct clinical features, disease variability, and extent of retinal dysfunction
-
Michaelides M, Jenkins SA, Brantley MA Jr, et al. Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction. Invest Ophthalmol Vis Sci 2006;47:3085-97.
-
(2006)
Invest Ophthalmol Vis Sci
, vol.47
, pp. 3085-3097
-
-
Michaelides, M.1
Jenkins, S.A.2
Brantley Jr., M.A.3
-
32
-
-
33644691312
-
Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression
-
Roybal CN, Marmorstein LY, Vander Jagt DL, Abcouwer SF. Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression. Invest Ophthalmol Vis Sci 2005;46:3973-9.
-
(2005)
Invest Ophthalmol Vis Sci
, vol.46
, pp. 3973-3979
-
-
Roybal, C.N.1
Marmorstein, L.Y.2
Vander Jagt, D.L.3
Abcouwer, S.F.4
-
33
-
-
78649955066
-
Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma
-
Hirayama N, Tabata C, Tabata R, et al. Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma. Respir Med 2011;105:137-42.
-
(2011)
Respir Med
, vol.105
, pp. 137-142
-
-
Hirayama, N.1
Tabata, C.2
Tabata, R.3
-
34
-
-
79952347899
-
Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications
-
Fiorelli A, Vicidomini G, Di DM, et al. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications. Interact Cardiovasc Thorac Surg 2011;12:420-4.
-
(2011)
Interact Cardiovasc Thorac Surg
, vol.12
, pp. 420-424
-
-
Fiorelli, A.1
Vicidomini, G.2
Di, D.M.3
|